# Collection of Transplant Stem Cells for Plasma Cell Myeloma

> **NCT01547806** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 49 (actual)

## Conditions studied

- Plasma Cell Myeloma
- Multiple Myeloma

## Interventions

- **DRUG:** Filgrastim
- **DRUG:** Plerixafor
- **PROCEDURE:** Apheresis

## Key facts

- **NCT ID:** NCT01547806
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-22
- **Primary completion:** 2014-06-17
- **Final completion:** 2018-01-11
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547806, "Collection of Transplant Stem Cells for Plasma Cell Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01547806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*